Benzinga's Top Upgrades

Analysts at Goldman Sachs upgraded Johnson & Johnson (NYSE: JNJ ) from “sell” to “neutral.” The target price for Johnson & Johnson has been raised from $87 to $95. Johnson & Johnson's shares closed at $87.78 yesterday. Bank of America upgraded Assurant (NYSE: AIZ ) from “underperform” to “neutral.”